Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Flavin adenine dinucleotide status and the effects of high-dose riboflavin treatment in short-chain acyl-CoA dehydrogenase deficiency.

Pediatric research - 1 Mar 2010

van Maldegem Bianca T, Duran Marinus, Wanders Ronald J A, Waterham Hans R, Wijburg Frits A

Abstract excerpt

Short-chain acyl-CoA dehydrogenase deficiency (SCADD) is an inborn error, biochemically characterized by increased plasma butyrylcarnitine (C4-C) concentration and increased ethylmalonic acid (EMA) excretion and caused by rare mutations and/or common gene variants in the SCAD encoding gene. Altho...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Carnitine
Share to Flavin-Adenine Dinucleotide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infant

Share to Lipid Metabolism, Inborn Errors

Share to Riboflavin

Share to Treatment Outcome

Share to Vitamin B Complex

Source

Identifiers

PMID: 19952864
DOI: 10.1203/PDR.0b013e3181cbd57b

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19952864-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Flavin adenine dinucleotide status and the effects of high-dose riboflavin treatment in short-chain acyl-CoA dehydrogenase deficiency.PMID 19952864Read ↗

Short-chain acyl-coenzyme A dehydrogenase deficiency.Semantic proximity Read ↗

Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency.Semantic proximity Read ↗

Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency.Semantic proximity Read ↗

Riboflavin in Neurological Diseases: A Narrative Review.Semantic proximity Read ↗

Hyperhomocysteinemia in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.Semantic proximity Read ↗

The frequency of short-chain acyl-CoA dehydrogenase gene variants in the US population and correlation with the C(4)-acylcarnitine concentration in newborn blood spots.Semantic proximity Read ↗

Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10).Semantic proximity Read ↗

Riboflavin Deficiency-Implications for General Human Health and Inborn Errors of Metabolism.Semantic proximity Read ↗

First case report of short-chain acyl-CoA dehydrogenase deficiency in China.Semantic proximity Read ↗

Riboflavin-responsive epilepsy in a patient with SER209 variant form of short-chain acyl-CoA dehydrogenase.Semantic proximity Read ↗

Short-chain and medium-chain acylCoA dehydrogenases are lowered in riboflavin-responsive lipid myopathies with multiple acylCoA dehydrogenase deficiency.Semantic proximity Read ↗

Role of common gene variations in the molecular pathogenesis of short-chain acyl-CoA dehydrogenase deficiency.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.